FTSE MIB
34.249,77 +310,02 (+0,91%) Dow Jones
38.239,66 +153,86 (+0,40%) Nasdaq
15.927,90 +316,14 (+2,03%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
83,66 +0,09 (+0,11%) Bitcoin EUR
59.289,93 +531,88 (+0,91%)
Pharming Group N.V. (0QCO.IL)
| Chiusura precedente | 0,8800 |
| Aperto | 0,8915 |
| Denaro | 0,8775 x 0 |
| Lettera | 0,9225 x 0 |
| Min-Max giorno | 0,8910 - 0,9030 |
| Intervallo di 52 settimane | 0,8620 - 1,3120 |
| Volume | |
| Media Volume | 1.129.548 |
| Capitalizzazione | 697,825M |
| Beta (5 anni mensile) | 0,87 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,0200 |
| Prossima data utili | N/D |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswirePharming Group to report third quarter 2023 financial results on October 26
Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2023 financial results, for the period ended September 30, on Thursday, October 26, 2023. Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 EDT on October 26, 2023. To participate in the conference call, please register in advance using the link below. Once registered, dial-in informat
- GlobeNewswire
Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
Leiden, The Netherlands, September 25, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted all proposals on the EGM agenda. Shareholders approved the appointment of Dr. Richard Peters as Non-Executive director for a period of four years. As a result, Dr. Peters succeeds Mr. Paul Sekhri as Chair of the Board of Directors with immediate effect. Deborah Jorn, Vice-Chair of the
